Pierre Jacquet - 08 Jun 2023 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 Jun 2023, 16:25:46 UTC
Prior SEC filing
13 Jun 2022
Next SEC filing
02 Jan 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Pierre Jacquet by Mark Busch, attorney-in-fact

Key filing fact

Pierre Jacquet filed Form 4 for EXACT SCIENCES CORP (EXAS) on 12 Jun 2023.

Key facts

  • This page summarizes Pierre Jacquet's Form 4 filing for EXACT SCIENCES CORP (EXAS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Jun 2023, 16:25.

Change

  • Previous filing in this sequence was filed on 13 Jun 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXAS transaction

Common Stock

Award

Transaction value
$0
Shares
+4,580
Change %
+24%
Price
$0.000000
Shares after
23,576
Date
08 Jun 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .